School of Engineering and Center for Biomedical Engineering, Brown University, Providence, Rhode Island 02912, USA; email:
Koch Institute for Integrative Cancer Research and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Annu Rev Biomed Eng. 2020 Jun 4;22:1-24. doi: 10.1146/annurev-bioeng-060418-052350. Epub 2020 Feb 21.
Controlled drug delivery formulations have revolutionized treatments for a range of health conditions. Over decades of innovation, layer-by-layer (LbL) self-assembly has emerged as one of the most versatile fabrication methods used to develop multifunctional controlled drug release coatings. The numerous advantages of LbL include its ability to incorporate and preserve biological activity of therapeutic agents; coat multiple substrates of all scales (e.g., nanoparticles to implants); and exhibit tuned, targeted, and/or responsive drug release behavior. The functional behavior of LbL films can be related to their physicochemical properties. In this review, we highlight recent advances in the development of LbL-engineered biomaterials for drug delivery, demonstrating their potential in the fields of cancer therapy, microbial infection prevention and treatment, and directing cellular responses. We discuss the various advantages of LbL biomaterial design for a given application as demonstrated through in vitro and in vivo studies.
控释药物制剂的出现彻底改变了多种健康状况的治疗方法。经过几十年的创新,层层自组装已成为用于开发多功能控释药物释放涂层的最通用的制造方法之一。层层自组装的众多优点包括能够掺入和保持治疗剂的生物活性;涂覆多种不同尺度的基底(例如,纳米颗粒到植入物);并表现出可调、靶向和/或响应性的药物释放行为。层层自组装薄膜的功能行为与其物理化学性质有关。在这篇综述中,我们重点介绍了用于药物输送的层层设计生物材料的最新进展,展示了它们在癌症治疗、微生物感染预防和治疗以及指导细胞反应等领域的潜力。我们讨论了通过体外和体内研究证明的,针对特定应用的层层生物材料设计的各种优势。